Yayınlar & Eserler

Yayın Ağı
Makaleler 19
Tümü (19)
SCI-E, SSCI, AHCI (15)
SCI-E, SSCI, AHCI, ESCI (15)
Scopus (15)
TRDizin (3)
Diğer Yayınlar (2)

1. Factors affecting survival and recurrence in patients with operated non-small cell lung cancer

GÜLMEZ A., ELKIRAN E.
Annals of Medical Research , cilt.30, sa.2, ss.272-277, 2023 (TRDizin) identifier

2. Tyrosine kinase inhibitors in the treatment of metastatic renal cell cancer patients with early cytokine intolerance: TURCOS, a Turkish national, prospective observational study

BENEKLİ M., Gumus M., ÖZKAN M., Dane F., ELKIRAN E. T., ÇİÇİN İ., et al.
JOURNAL OF ONCOLOGY PHARMACY PRACTICE , cilt.27, sa.7, ss.1623-1630, 2021 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

3. Is eribulin treatment prognostic factor in patients with metastatic breast cancer treated with this drug? Retrospective analysis of a multicentre study

Oruc Z., Kaplan M. A., Geredeli C., Sari N. Y., Ozaslan E., Aytekin A., et al.
JOURNAL OF BUON , cilt.24, sa.5, ss.1876-1883, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

4. The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study

Kaplan M. A., Oruc Z., Gumus M., Ozaydm S., ELKIRAN E. T., Dine N. S., et al.
JOURNAL OF BUON , cilt.24, sa.3, ss.1081-1086, 2019 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

5. A rare case: a lung cancer with maxillary metastasis

GÜLMEZ A., GÜLBAŞ H., ÖZCAN M., ELKIRAN E. T.
Cancer Reports and Reviews , cilt.3, 2019 (Hakemli Dergi)

6. Effectiveness and Safety of LMWH Treatment in Patients With Cancer Diagnosed With Non-High-Risk Venous Thromboembolism: Turkish Observational Study (TREBECA)

Ozaslan E., ÖZKAN M., ÇİÇİN İ., BENEKLİ M., Kocer M., UYSAL M., et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , cilt.24, sa.6, ss.973-979, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

7. Prognostic factors of patients who received chemotherapy after cranial irradiation for non-small cell lung cancer with brain metastases: A retrospective analysis of multicenter study (Anatolian Society of Medical Oncology)

Inal A., Kodaz H., Odabas H., Duran A. O., ŞEKER M. M., Inanc M., et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS , cilt.14, sa.3, ss.578-582, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

8. POSTERIOR REVERSIBLE LEUKOENCEPHALOPATHY SYNDROME DEVELOPING SECONDARY TO SUNITINIB THERAPY IN A PATIENT WITH METASTATIC RENAL CELL CARCINOMA

Kaplan N. B., HARPUTLUOĞLU H., Dikilitas M., ELKIRAN E. T., TEMELLİ Ö.
ACTA MEDICA MEDITERRANEA , cilt.34, sa.1, ss.39-42, 2018 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier

9. Oxidative stress and antioxidant parameters in neutropenic patients secondary to chemotherapy

Dogantekin A., Gurel A., ÜSTÜNDAĞ B., Ilhan S., ELKIRAN E. T.
PAKISTAN JOURNAL OF MEDICAL SCIENCES , cilt.32, sa.2, ss.309-313, 2016 (SCI-Expanded, Scopus) identifier identifier identifier

10. The effect of the gastrectomy on survival in patients with metastatic gastric cancer: a study of ASMO

Yazici O., Ozdemir N., Duran A. O., Menekse S., Ali M., Sendur N., et al.
FUTURE ONCOLOGY , cilt.12, sa.3, ss.343-354, 2016 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

11. The significance of MPV and N L value in diagnosis of endometrial cancer

YILMAZ E., İNCİ COŞKUN E., ŞAHİN N., ELKIRAN E. T., ÇIPLAK B., ŞİMŞEK Ö. Y.
The Turkish Journal of Gynecologic Oncology , cilt.19, sa.1, ss.33-36, 2016 (Hakemli Dergi)

12. Outcomes of radiotherapy in early stage glottic laryngeal carcinoma a single center experience

EKİCİ K., TEMELLİ O., ERASLAN A., GUROCAK S., KAPLAN BOZDAG N., ELKIRAN E. T., et al.
Medicine Science | International Medical Journal , cilt.5, sa.4, ss.928, 2016 (TRDizin)

13. Efficacy of sorafenib in advanced differentiated and medullary thyroid cancer: experience in a Turkish population

BENEKLİ M., YALÇIN Ş., ÖZKAN M., ELKIRAN E. T., Sevinc A., ÇABUK D., et al.
ONCOTARGETS AND THERAPY , cilt.8, ss.1-5, 2015 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

14. Clinical outcomes in patients who received lapatinib plus capecitabine combination therapy for HER2-positive breast cancer with brain metastasis and a comparison of survival with those who received trastuzumab-based therapy: a study by the Anatolian Society of Medical Oncology

Kaplan M. A., Isikdogan A., Koca D., KÜÇÜKÖNER M., Gumusay O., Yildiz R., et al.
BREAST CANCER , cilt.21, sa.6, ss.677-683, 2014 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

15. Investigation of hepatocyte growth factor and proinflammatory cytokine levels in patients with febrile neutropenia

ÖZDEN M., Godekmerdan A., İLHAN N. F., ELKIRAN E. T., Akbulut H. H.
TURKISH JOURNAL OF MEDICAL SCIENCES , cilt.43, sa.4, ss.599-605, 2013 (SCI-Expanded, Scopus, TRDizin) Sürdürülebilir Kalkınma identifier identifier

16. Clinical and Pathologic Features of Patients with Rare Ovarian Tumors: Multi-Center Review of 167 Patients by the Anatolian Society of Medical Oncology

Bilici A., Inanc M., Ulas A., Akman T., Seker M., Babacan N. A., et al.
ASIAN PACIFIC JOURNAL OF CANCER PREVENTION , cilt.14, sa.11, ss.6493-6499, 2013 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

17. Multicentric study on malignant pleural mesothelioma in Turkey: clinicopathologic and survival characteristics of 282 patients

ELKIRAN E. T., Kaplan M. A., Sevinc A., Aksoy S., Demirci U., Seker M., et al.
MEDICAL ONCOLOGY , cilt.29, sa.5, ss.3147-3154, 2012 (SCI-Expanded, Scopus) identifier identifier identifier

18. Biological Subtypes and Survival Outcomes in Breast Cancer Patients with Brain Metastases (Study of the Anatolian Society of Medical Oncology)

Kaplan M. A., Isikdogan A., Koca D., Kucukoner M., Gumusay O., Yildiz R., et al.
ONCOLOGY , cilt.83, sa.3, ss.141-150, 2012 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier

19. Ghrelin: A novel peptide with therapeutic effect in certain cancers?

Aydın S., Geckil H., KARAOGLU A., Elkiran E. T.
MEDICAL HYPOTHESES , cilt.69, sa.5, ss.1157-1158, 2007 (SCI-Expanded, Scopus) Sürdürülebilir Kalkınma identifier identifier identifier
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 3

1. Six-month follow-up after neoadjuvant chemotherapy and segmental resection for mandibular osteosarcoma

KUŞOĞLU F., ASLAN M., ARAL C. A., ELKIRAN E. T., DEDEOĞLU N., FIRAT ATAY F., et al.
54th International Scientific Congress and the 32nd Scientific Symposium of the Turkish Society of Periodontology, Ankara, Türkiye, 14 Kasım 2025, (Özet Bildiri)

2. Metastatic ovarian tumors originated from pancreas

İnci Coşkun E., Alan S., Yılmaz E., Kutlutürk K., Gökçe H., Akbulut A. S., et al.
I. International and XVI th National Gynecologic Oncology Congres, Antalya, Türkiye, 21 - 25 Kasım 2018, (Tam Metin Bildiri)

3. Metastatik ovarian tumors orginated from pancreas

İNCİ COŞKUN E., ALAN S., YILMAZ E., KUTLUTÜRK K., GÖKÇE H., AKBULUT A. S., et al.
1. International XVI. National Gynecologic Oncology Congress, 21 - 25 Kasım 2018, (Özet Bildiri)
Kitaplar 1

1. Hepatoselüler Karsinomada Cerrahi ve Transplantasyonun Yeri

KARAKAŞ S., İNCE V., ELKIRAN E. T., YILMAZ S.
Türkiye Klinikleri Tıbbi Onkoloji - Özel Konular, ÖZET Ahmet, ÖZDEMİR Nuriye, YAZICI Ozan, Editör, Türkiye Klinikleri Tıp Bilimleri Dergisi, Ankara, ss.23-31, 2021
Metrikler

Yayın

24

Yayın (WoS)

15

Yayın (Scopus)

15

Atıf (WoS)

64

H-İndeks (WoS)

5

Atıf (Scopus)

66

H-İndeks (Scopus)

5

Atıf (Scholar)

4

H-İndeks (Scholar)

1

Atıf (Diğer Toplam)

1

Proje

3

Tez Danışmanlığı

5
BM Sürdürülebilir Kalkınma Amaçları